Trikafta Increases Microbiome Diversity in Lungs, Study Shows

The microbiome diversity in the lungs of cystic fibrosis (CF) patients increased after treatment with Trikafta, becoming similar to a person without CF, an analysis showed. In addition, small molecule metabolites produced by cells varied widely across patients while on the therapy, with the largest decrease seen in amino acids (building blocks of protein) or [ŝThe post Trikafta Increases Microbiome Diversity in Lungs, Study Shows appeared first on Cystic Fibrosis News Today